Trump's Terms White House orders NIH to research trans 'regret' and 'detransition'
Apr 11, 2025
The podcast delves into the controversial directive from the Trump administration ordering the NIH to study gender transition effects, including regret and detransition. Researchers and LGBTQ advocates discuss the implications for public health and rights. It also highlights the surprisingly low rates of regret in gender-affirming care, raising concerns about the impact of reduced funding on transgender health research. The complexities surrounding regret in transition-related healthcare form a crucial part of the conversation.
AI Snips
Chapters
Transcript
Episode notes
Politicized Research
- The White House's directive to the NIH aims for a political, not scientific, answer regarding gender transition.
- This raises concerns about the scientific integrity of the NIH's research.
Offensive Language
- The directive's use of terms like "chemical and surgical mutilation" is offensive and stigmatizing.
- Such language is inappropriate for scientific discourse on evidence-based medical interventions.
Weaponizing Regret
- The focus on "regret and detransition" can be a manipulative tactic.
- Existing evidence shows that regret after gender transition is very low, less than 1%.